# Severe attenuation of circadian clock output in the heart following sustained augmentation of cardiomyocyte protein O-GlcNAcylation

**Authors:** Gobinath Shanmugam, Samuel F. Chang, Helen E. Collins, Chae-Myeong Ha, Mariame S. Kane, Luke Potter, Lily Xie, Luyun Zou, Jianhua Zhang, John C. Chatham, Adam R. Wende, Martin E. Young

PMC · DOI: 10.3389/fcvm.2025.1601407 · Frontiers in Cardiovascular Medicine · 2025-07-17

## TL;DR

Elevated O-GlcNAcylation in heart cells disrupts circadian rhythms and leads to heart fibrosis.

## Contribution

This study reveals that increased O-GlcNAcylation in cardiomyocytes impairs circadian control of the heart transcriptome.

## Key findings

- A 1.5-fold increase in O-GlcNAcylation impacts 70% of core circadian clock components in the heart.
- There is a 95% loss of circadian governance of the cardiac transcriptome despite normal oscillations of core clock proteins.
- Loss of circadian governance results in interstitial fibrosis in the heart.

## Abstract

Changes in circadian-related behaviors (e.g., the timing of food intake, sleep cycles) and the environment (e.g., light-dark cycles) increase the risk of numerous cardiometabolic diseases, including diabetes mellitus and cardiac disease. Recent studies indicate a close interrelationship between circadian clocks and the posttranslational modification, protein O-GlcNAcylation. The current study was designed to investigate whether a modest elevation of protein O-GlcNAcylation in the adult mouse heart, similar to levels observed during pathologic states, influenced circadian governance of the heart.

Cardiomyocyte-specific expression of a dominant negative O-GlcNAcase (dnOGAh) for a 2-week period resulted in an approximate 1.5-fold increase in cardiac protein O-GlcNAcylation, impacting 70% of core circadian clock components in the heart at the mRNA level. Further interrogation of cardiac mRNA species in dnOGAh hearts at candidate (RT-PCR) and unbiased (RNAseq) levels revealed a 95% loss of circadian governance of the cardiac transcriptome. This was despite persistent/augmented 24 h oscillations of the core circadian clock proteins BMAL1, REVERBα, and PER2 in dnOGAh hearts. Direct comparison of dnOGAh hearts with cardiomyocyte-specific BMAL1 knockout (CBK) hearts underscored an apparent uncoupling of the core clock mechanism from clock control of downstream target genes in dnOGAh hearts, and highlighted that loss of circadian governance results in interstitial fibrosis.

Sustained protein O-GlcNAcylation in the heart causes loss of circadian governance, likely downstream of the core circadian clock mechanism. Moreover, interstitial fibrosis appears to be a universal adverse outcome following impaired circadian governance.

## Linked entities

- **Genes:** BMAL1 (basic helix-loop-helix ARNT like 1) [NCBI Gene 406], NR1D1 (nuclear receptor subfamily 1 group D member 1) [NCBI Gene 9572], PER2 (period circadian regulator 2) [NCBI Gene 8864]
- **Proteins:** BMAL1 (basic helix-loop-helix ARNT like 1), NR1D1 (nuclear receptor subfamily 1 group D member 1), PER2 (period circadian regulator 2)
- **Diseases:** diabetes mellitus (MONDO:0005015), cardiac disease (MONDO:0005267)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Nr1d1 (nuclear receptor subfamily 1, group D, member 1) [NCBI Gene 217166] {aka A530070C09Rik}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Nr1d2 (nuclear receptor subfamily 1, group D, member 2) [NCBI Gene 353187] {aka RVR, Rev-erb}, Per1 (period circadian clock 1) [NCBI Gene 18626] {aka Hftm, Per, m-rigui, mPer1}, Bmal1 (basic helix-loop-helix ARNT like 1) [NCBI Gene 11865] {aka Arnt3, Arntl, BMAL1b, MOP3, bHLHe5, bmal1b'}, Cry1 (cryptochrome circadian regulator 1) [NCBI Gene 12952] {aka Phll1}, Clock (clock circadian regulator) [NCBI Gene 12753] {aka 5330400M04Rik, KAT13D}, Rhobtb1 (Rho-related BTB domain containing 1) [NCBI Gene 69288] {aka 1700008H16Rik, 3110048G13Rik}, Dbp (D site albumin promoter binding protein) [NCBI Gene 13170], Per2 (period circadian clock 2) [NCBI Gene 18627] {aka mKIAA0347, mPer2}, Col4a1 (collagen, type IV, alpha 1) [NCBI Gene 12826] {aka Bru, Col4a-1, Raw, Svc}, OGT (O-linked N-acetylglucosamine (GlcNAc) transferase) [NCBI Gene 8473] {aka HINCUT-1, HRNT1, MRX106, O-GLCNAC, OGT1, XLID106}, Cry2 (cryptochrome circadian regulator 2) [NCBI Gene 12953] {aka D130054K12Rik}, Per3 (period circadian clock 3) [NCBI Gene 18628] {aka 2810049O06Rik, mPer3}, Nfil3 (nuclear factor, interleukin 3, regulated) [NCBI Gene 18030] {aka E4BP4}, Ogt (O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase)) [NCBI Gene 108155] {aka 1110038P24Rik, 4831420N21Rik, Ogtl}, Col3a1 (collagen, type III, alpha 1) [NCBI Gene 12825] {aka Col3a-1, Tsk-2, Tsk2}, Dgat2 (diacylglycerol O-acyltransferase 2) [NCBI Gene 67800] {aka 0610010B06Rik, ARAT, DGAT-2}, Hlf (hepatic leukemia factor) [NCBI Gene 217082] {aka E230015K02Rik}, Oga (O-GlcNAcase) [NCBI Gene 76055] {aka Hy5, Mgea5, Ncoat}, Myh6 (myosin, heavy polypeptide 6, cardiac muscle, alpha) [NCBI Gene 17888] {aka A830009F23Rik, Myhc-a, Myhca, alpha-MHC, alphaMHC}, Nampt (nicotinamide phosphoribosyltransferase) [NCBI Gene 59027] {aka 1110035O14Rik, NAmPRTase, Pbef, Pbef1, Visfatin}, Npas2 (neuronal PAS domain protein 2) [NCBI Gene 18143] {aka MOP4, bHLHe9}, Col1a1 (collagen, type I, alpha 1) [NCBI Gene 12842] {aka Col1a-1, Cola-1, Cola1, Mov-13, Mov13}, Tef (thyrotroph embryonic factor) [NCBI Gene 21685] {aka 2310028D20Rik}
- **Diseases:** diastolic dysfunction (MESH:D018487), ischemia (MESH:D007511), heart failure (MESH:D006333), diabetes (MESH:D003920), cardiovascular disease (MESH:D002318), hypertrophy (MESH:D006984), pressure overload (MESH:D019190), Interstitial fibrosis (MESH:D005355), cardiometabolic diseases (MESH:D024821), cardiac remodeling (MESH:D020257), cardiac disease (MESH:D006331), cardiac hypertrophy (MESH:D006332)
- **Chemicals:** paraffin (MESH:D010232), hexosamine (MESH:D006595), tetracycline (MESH:D013752), PVDF (MESH:C024865), ethanol (MESH:D000431), CBK (-), amido black (MESH:D000580), formalin (MESH:D005557), threonine (MESH:D013912), carbon (MESH:D002244), NaCl (MESH:D012965), glucose (MESH:D005947), serine (MESH:D012694), amino acids (MESH:D000596), DOX (MESH:D004318), fatty acids (MESH:D005227), polyacrylamide (MESH:C016679), Picrosirius Red (MESH:C009798)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12310464/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12310464/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12310464/full.md

---
Source: https://tomesphere.com/paper/PMC12310464